PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs ARRY |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc. | 0.17 | 11.7 | 69.3% | — |
| EXEL | Exelixis, Inc. | 0.34 | 17.8 | 51.6% | — |
| FSLR | First Solar, Inc. | 0.44 | 13.4 | 30.5% | — |
| NXT | Nextpower Inc. | 6.17 | 25.7 | 4.2% | — |